日本語 
Pharma
Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains setmelanotide, which helps patients who have acquired obesity. The launch is possible because the medicine was added to…
Chugai Pharmaceutical to Acquire Renalys Pharma
Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys…
Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy
Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…
Taiho Pharma Exercises Exclusive License for Casdatifan
Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…
Alpha Fusion and Kobe Hospital launch At-211 Drug system
Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…
Rentschler Biopharma Expands in Japan and Korea
Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…
Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
Elix, Inc. and the Graduate School of Life Sciences at Tohoku University…
CM Plus launches “pharmo.AI” for pharma research support
CM Plus Co., Ltd. has officially released "pharmo.AI," an AI search system…
Chugai Pharmaceutical to Acquire Renalys Pharma
Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys…
Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy
Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…
Taiho Pharma Exercises Exclusive License for Casdatifan
Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…
Alpha Fusion and Kobe Hospital launch At-211 Drug system
Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…
Rentschler Biopharma Expands in Japan and Korea
Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…
Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
Elix, Inc. and the Graduate School of Life Sciences at Tohoku University…
CM Plus launches “pharmo.AI” for pharma research support
CM Plus Co., Ltd. has officially released "pharmo.AI," an AI search system…
English